CD274 and non-small cell lung carcinoma: Previous findings showed that increased levels of polyunsaturated FAs (PUFAs) within the cell membrane can improve the efficacy of non-small cell lung cancer (NSCLC) to anti-PD-1 and anti-PD-L1 immunotherapy.